Azarani A, Goltzman D, Orlowski J
Department of Physiology, McGill University, Montreal, Quebec, Canada.
J Biol Chem. 1995 Aug 25;270(34):20004-10. doi: 10.1074/jbc.270.34.20004.
Parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHRP) interact with a common G protein-coupled receptor and stimulate production of diverse second messengers (i.e. cAMP, diacylglycerol, and inositol 1,4,5-trisphosphate) that varies depending on the target cell. In renal proximal tubule OK cells, PTH inhibits the activity of the apical membrane Na+/H+ exchanger, although it is unclear whether the signal is transmitted through protein kinase A (PKA) and/or protein kinase C (PKC). To delineate the signaling circuitry, a series of synthetic PTH and PTHRP fragments were used that stimulate the adenylate cyclase-cAMP-PKA and/or phospholipase C-diacylglycerol-PKC pathways. Human PTH-(1-34) and PTHRP-(1-34) stimulated adenylate cyclase and PKC activity, whereas the PTH analogues, PTH-(3-34), PTH-(28-42), and PTH-(28-48), selectively enhanced only PKC activity. However, each peptide fragment inhibited Na+/H+ exchanger activity by 40-50%, suggesting that PKC and possibly PKA were capable of transducing the PTH/PTHRP signal to the transporter. This was corroborated when forskolin and phorbol 12-myristate 13-acetate (PMA), direct agonists of adenylate cyclase and PKC, respectively, both inhibited the Na+/H+ exchanger. The specific PKA antagonist, H-89, abolished the forskolin-mediated suppression of Na+/H+ exchanger activity, but did not prevent the inhibitory effects of PTH-(1-34) or PMA. In comparison, the potent PKC inhibitor, chelerythrine chloride, prevented the inhibition of Na+/H+ exchanger activity mediated by PTH-(28-48) and PMA but did not avert the negative regulation caused by PTH-(1-34) or forskolin. However, inhibition of both PKA and PKC prevented PTH-(1-34)-mediated suppression of Na+/H+ exchanger activity, indicating that PTH-(1-34) acted through both signaling pathways. In addition, Northern blot analysis revealed the presence of only the NHE-3 isoform of the Na+/H+ exchanger in OK cells. In summary, these results demonstrated that NHE-3 is expressed in OK cells and that activation of the PTH receptor can stimulate both the PKA and PKC pathways, each of which can independently lead to inhibition of NHE-3 activity.
甲状旁腺激素(PTH)和甲状旁腺激素相关肽(PTHRP)与一种常见的G蛋白偶联受体相互作用,并刺激产生多种第二信使(即环磷酸腺苷(cAMP)、二酰基甘油和肌醇1,4,5-三磷酸),这些第二信使会因靶细胞的不同而有所变化。在肾近端小管OK细胞中,PTH会抑制顶端膜Na⁺/H⁺交换体的活性,不过尚不清楚该信号是否通过蛋白激酶A(PKA)和/或蛋白激酶C(PKC)进行传递。为了阐明信号传导途径,使用了一系列合成的PTH和PTHRP片段,这些片段可刺激腺苷酸环化酶 - cAMP - PKA和/或磷脂酶C - 二酰基甘油 - PKC途径。人PTH - (1 - 34)和PTHRP - (1 - 34)刺激腺苷酸环化酶和PKC活性,而PTH类似物PTH - (3 - 34)、PTH - (28 - 42)和PTH - (28 - 48)仅选择性增强PKC活性。然而,每个肽片段都能将Na⁺/H⁺交换体的活性抑制40% - 50%,这表明PKC以及可能的PKA能够将PTH/PTHRP信号传递给该转运体。当分别作为腺苷酸环化酶和PKC直接激动剂的福斯高林和佛波醇12 - 肉豆蔻酸酯13 - 乙酸酯(PMA)都抑制Na⁺/H⁺交换体时,这一点得到了证实。特异性PKA拮抗剂H - 89消除了福斯高林介导的对Na⁺/H⁺交换体活性的抑制作用,但并未阻止PTH - (1 - 34)或PMA的抑制作用。相比之下,强效PKC抑制剂氯化白屈菜红碱可防止PTH - (28 - 48)和PMA介导的对Na⁺/H⁺交换体活性的抑制作用,但无法避免PTH - (1 - 34)或福斯高林引起的负调控。然而,同时抑制PKA和PKC可防止PTH - (1 - 34)介导的对Na⁺/H⁺交换体活性的抑制作用,这表明PTH - (1 - 34)通过两条信号传导途径发挥作用。此外,Northern印迹分析显示OK细胞中仅存在Na⁺/H⁺交换体的NHE - 3亚型。总之,这些结果表明NHE - 3在OK细胞中表达,并且PTH受体的激活可刺激PKA和PKC两条途径,每条途径均可独立导致NHE - 3活性受到抑制。